PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model
Chinami Masuda(Chugai Pharma (United States)), Masamichi Sugimoto(Chugai Pharma (United States))
Cited by 5
Related Papers
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
|Clinical & Experimental Metastasis|2019|38